Concepedia

A Dose-Escalating Study of Weekly Bolus Topotecan in Previously Treated Ovarian Cancer Patients

Howard D. Homesley, Don Hall, George Lewandowski, Luis Vaccarello, William A. Nahhas, Charles L. Suggs, Rebecca G. Penley

Gynecologic Oncology · 2001 · 82 citations · 21 references

DOI

Concepts

References

21

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

, , +16

Accelerated Titration Designs for Phase I Clinical Trials in Oncology

Richard Simon, Larry Rubinstein, Susan G. Arbuck et al. · JNCI Journal of the National Cancer Institute · 1997 · 640 citations · Full text

, , +17

Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer

Jan P. Neijt, Svend Aage Engelholm, Malgorzata Tuxen et al. · Journal of Clinical Oncology · 2000 · 443 citations

, , +17

Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study.

G.J. Creemers, Giorgio Bolis, M. Gore et al. · Journal of Clinical Oncology · 1996 · 386 citations

, , +17

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor.

Eric K. Rowinsky, L B Grochow, Carolyn B. Hendricks et al. · Journal of Clinical Oncology · 1992 · 358 citations

, , +15